Live feed
Filing
SC 13G/A
SC 13G/A0001273087-24-000095·Aclaris Therapeutics, Inc.
Schedule 13G ownership disclosure
Aclaris Therapeutics Inc
Security class unavailable · CUSIP: 00461U105
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001273087-24-000095
- Form type
- SC 13G/A
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Oct 09, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership